tradingkey.logo
tradingkey.logo
Search

Becton Dickinson and Co

BDX
Add to Watchlist
152.940USD
-0.220-0.14%
Close 07-23 16:00ETQuotes delayed by 15 min
42.14BMarket Cap
38.53P/E TTM

Becton Dickinson and Co

152.940
-0.220-0.14%
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-0.14%

5 Days

-4.37%

1 Month

+6.27%

6 Months

-3.56%

Year to Date

+0.28%

1 Year

+6.59%

Key Figures
153.355Open
154.280High
1.61MVolume
38.53P/E TTM
11.33P/E Dynamic
4.180Dividend TTM
0.58%Turnover Ratio
153.160Prev. Close
152.135Low
128.24MTurnover
25.11P/E Static
1.75P/B
2.73%Div Yield TTM
3.13%ROA
187.35052wk High
1.00Volume Ratio
1.68BNet Profit
275.54MShares
3.9693EPS TTM
0.23Beta
6.67%ROE
127.53652wk Low
1.40%Amplitude
46.58%Gross Margin
42.14BMarket Cap
2.46Reward/Risk
1.48%Risk Rate

Key Insights

Becton Dickinson and Co's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 65 out of 200 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 185.39.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Becton Dickinson and Co's Score

Industry at a Glance

Industry Ranking
65 / 200
Overall Ranking
141 / 4547
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Becton Dickinson and Co Highlights

StrengthsRisks
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 21.84B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 71.28%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 71.28%.
Fairly Valued
The company’s latest PE is 38.54, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 241.06M shares, decreasing 16.25% quarter-over-quarter.
Held by First Pacific Advisors
Star Investor First Pacific Advisors holds 2.11M shares of this stock.

Analyst Rating

Based on 16 analysts
Buy
Current Rating
185.389
Target Price
+20.51%
Upside Space

Becton Dickinson and Co News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 16 analysts
Buy
Current Rating
185.389
Target Price
+20.51%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Becton Dickinson and Co
BDX
16
Medtronic PLC
MDT
34
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22

Indicators

Indicators
Sell(3)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.488
Neutral
RSI(14)
50.846
Neutral
STOCH(KDJ)(9,3,3)
35.432
Sell
ATR(14)
4.122
High Vlolatility
CCI(14)
-33.153
Neutral
Williams %R
68.209
Sell
TRIX(12,20)
0.188
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
154.524
Sell
MA10
154.385
Sell
MA20
154.095
Sell
MA50
149.407
Buy
MA100
152.964
Sell
MA200
154.605
Sell

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Becton Dickinson and Co Info

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
Ticker SymbolBDX
CompanyBecton Dickinson and Co
CEOPolen (Thomas E)
Websitehttps://www.bd.com/

Shareholders

Shareholders
Shareholders
Proportion
Vanguard Capital Management, LLC
6.71%
Vanguard Portfolio Management, LLC
5.56%
BlackRock Institutional Trust Company, N.A.
5.41%
T. Rowe Price Investment Management, Inc.
5.22%
State Street Investment Management (US)
5.08%
Other
72.02%

FAQs

What is the current price of Becton Dickinson and Co (BDX)?

The current price of Becton Dickinson and Co (BDX) is 152.94.

What is the symbol of Becton Dickinson and Co?

The ticker symbol of Becton Dickinson and Co is BDX.

What is the 52-week high of Becton Dickinson and Co?

The 52-week high of Becton Dickinson and Co is 187.35.

What is the 52-week low of Becton Dickinson and Co?

The 52-week low of Becton Dickinson and Co is 127.54.

What is the market capitalization of Becton Dickinson and Co?

The market capitalization of Becton Dickinson and Co is 42.14B.

Is Becton Dickinson and Co (BDX) currently rated as Buy, Hold, or Sell?

According to analysts, Becton Dickinson and Co (BDX) has an overall rating of Buy, with a price target of 185.39.

What is the Earnings Per Share (EPS TTM) of Becton Dickinson and Co (BDX)?

The Earnings Per Share (EPS TTM) of Becton Dickinson and Co (BDX) is 5.83.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.